|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online July 23, 2007
doi: 10.1242/10.1242/jcs.007344
Research Article |
1 Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
2 Molecular Medicine Unit-Department of Medicine, Center for Cancer Research (CIC), University of Salamanca, Salamanca, Spain
3 Leukaemia Research Fund Centre at the Institute of Cancer Research, London, UK
4 Confocal Microscopy and Cytometry Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
5 Department of Histology (University of Granada) and Fundación Hospital Clínico, Granada, Spain
* Authors for correspondence (e-mails: gonzalez{at}usal.es; eballestar{at}cnio.es)
Accepted 26 May 2007
The transcription factor Aiolos (also known as IKZF3), a member of the Ikaros family of zinc-finger proteins, plays an important role in the control of B lymphocyte differentiation and proliferation. Previously, multiple isoforms of Ikaros family members arising from differential splicing have been described and we now report a number of novel isoforms of Aiolos. It has been demonstrated that full-length Ikaros family isoforms localize to heterochromatin and that they can associate with complexes containing histone deacetylase (HDAC). In this study, for the first time we directly investigate the cellular localization of various Aiolos isoforms, their ability to heterodimerize with Ikaros and associate with HDAC-containing complexes, and the effects on histone modification and binding to putative targets. Our work demonstrates that the cellular activities of Aiolos isoforms are dependent on combinations of various functional domains arising from the differential splicing of mRNA transcripts. These data support the general principle that the function of an individual protein is modulated through alternative splicing, and highlight a number of potential implications for Aiolos in normal and aberrant lymphocyte function.
Key words: Aiolos, Chromatin, Epigenetics, Ikaros, Isoforms, Mi-2/NuRD
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Duhamel, I. Arrouss, H. Merle-Beral, and A. Rebollo The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia Blood, March 15, 2008; 111(6): 3225 - 3228. [Abstract] [Full Text] [PDF] |
||||